Atlas Venture

About The Fund

Atlas Venture, founded in 1980 and based in Cambridge, Massachusetts, is a well-established venture capital firm with a focus on life sciences, biotechnology, and drug discovery sectors. With a rich history spanning over three decades, they specialize in building breakthrough biotechnology companies and boast a long track record of creating and nurturing startups in the life sciences industry. Atlas Venture uniquely combines deep scientific and business expertise to translate groundbreaking science into life-changing medicines. The firm's investment approach is tailored to the early stages of a company's development, primarily engaging in Seed, Series A, and Series B rounds of financing. Atlas Venture invests with a minimum amount of $10 million and can invest up to $50 million, with a sweet spot of $25 million for investments. This flexible investment range allows them to support a variety of company stages and needs. Atlas Venture has launched over 70 startups from their incubator and has seen impressive success with more than 25 medicines developed by their portfolio companies reaching the market. Their impact is further highlighted by their participation in 40 IPOs and 34 mergers and acquisitions, marking them as a significant player in the biotechnology investment space. Their investment portfolio includes breakthrough biotechs that develop innovative healthcare solutions in areas such as pharmaceuticals, medical devices, and healthtech, as well as consumer-focused health and wellness products. With a mission to partner with the world's best life science entrepreneurs, they work closely with founders to nurture early-stage companies capable of making a genuine impact on patient health. The fund's commitment to innovation is reflected not only in their selective investment choices but also in their involvement with their portfolio companies throughout the growth process.